Literature DB >> 19252854

Affinity maturation by phage display.

Holger Thie1, Bernd Voedisch, Stefan Dübel, Michael Hust, Thomas Schirrmann.   

Abstract

Antibodies are indispensable tools for research, diagnostics, and therapy. However, sometimes antibodies with the most favourable specificity profile lack sufficient affinity for a desired application. Here, we describe a method to increase the affinity of recombinant scFv antibody fragments based on random mutagenesis and phage display under stringent conditions. Random mutations are inserted by performing several rounds of error-prone PCR. After construction of a mutated antibody gene library, affinity selection is performed by panning with washing conditions optimized for off-rate-dependent selection. Alternatively, panning in solution with competition can be used to enrich binders with improved binding properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252854     DOI: 10.1007/978-1-59745-554-1_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

Review 1.  Engineering the variable region of therapeutic IgG antibodies.

Authors:  Tomoyuki Igawa; Hiroyuki Tsunoda; Taichi Kuramochi; Zenjiro Sampei; Shinya Ishii; Kunihiro Hattori
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

2.  Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.

Authors:  Y T Ong; K A Kirby; A Hachiya; L A Chiang; B Marchand; K Yoshimura; T Murakami; K Singh; S Matsushita; S G Sarafianos
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2012-12-22       Impact factor: 1.770

3.  A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.

Authors:  Jianying Dong; Arlene Sereno; Dikran Aivazian; Emma Langley; Brian R Miller; William B Snyder; Eric Chan; Matt Cantele; Ronald Morena; Ingrid B J K Joseph; Antonio Boccia; Cyrus Virata; James Gamez; Grace Yco; Michael Favis; Xiufeng Wu; Christilyn P Graff; Qin Wang; Ellen Rohde; Rachel Rennard; Lisa Berquist; Flora Huang; Ying Zhang; Sharon X Gao; Steffan N Ho; Stephen J Demarest; Mitchell E Reff; Kandasamy Hariharan; Scott M Glaser
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

4.  Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor.

Authors:  Laila Al-Halabi; Anne Balck; Monika Michalzik; David Fröde; Stephanus Büttgenbach; Michael Hust; Thomas Schirrmann; Stefan Dübel
Journal:  MAbs       Date:  2012-12-06       Impact factor: 5.857

Review 5.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

6.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 7.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

8.  Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms.

Authors:  Michael R Kierny; Thomas D Cunningham; Brian K Kay
Journal:  Nano Rev       Date:  2012-07-23

9.  Isolation and characterisation of a recombinant antibody fragment that binds NCAM1-expressing intervertebral disc cells.

Authors:  Claire Cunningham; Akshay Srivastava; Estelle Collin; Sibylle Grad; Mauro Alini; Abhay Pandit; J Gerard Wall
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.

Authors:  Sujatha P Koduvayur; Hélène A Gussin; Rajni Parthasarathy; Zengping Hao; Brian K Kay; David R Pepperberg
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.